Building more relevant human model systems to explore complex cardiovascular biology is essential as we work to uncover new therapeutic treatment options for heart failure. Dr. MacDonnell will share the rationale and development of human-based cardiac cellular and tissue model systems.
Presented by:
Regeneron Pharmaceuticals in the department of Cardiovascular, Fibrosis, and Renal Disease
View SlidesSave the date!
Please join on May 16-17, 2024